SLE & Immune System Disorders

What is SLE

Systemic Lupus Erythematosus (SLE), is the most common type of lupus. SLE is an autoimmune disease in which the immune system attacks its own tissues, causing widespread inflammation and tissue damage in the affected organs. It can affect the joints, skin, brain, lungs, kidneys, and blood vessels. 

Immune System Disorders

Immune System Disorders cause abnormally low activity or over activity of the immune system. In cases of immune system overactivity, the body attacks and damages its own tissues (autoimmune diseases). Immune deficiency diseases decrease the body's ability to fight invaders, causing vulnerability to infections.

SICKNESS: SLE & Immune System Disorders

BENEFITS THRU’ DXN PRODUCTS:

- Improves & Balances ALL the immune System functions
- Improves Energy and reduces dependence on Drugs
- Extends life-span; Improves Q of life
- Reduces the risk of frequent ‘Infection’
- Improves Energy and Stamina

PRODUCTS RECOMMENDATIONS:

• RG
• GL
• DXN Spirulina
• DXN Lion's Mane
• DXN Morinzhi
• DXN Cordypine

DISCLAIMER: The dietary food supplements presented in this Page are designed to assist in the maintenance of general well-being through regular use. If you have a condition which requires medical diagnosis and treatment, it is important that you visit your healthcare professional.

The information presented on this page is for informational & educational purposes only, and is not intended as a medical advice or a substitute for a physician’s consultation and/or examination.

Liver Problem & Solution

SICKNESS: Liver Diseases

It helps your body digest food, store energy, and remove poisons. There are many kinds of liver diseases: Diseases caused by viruses, such as hepatitis A, hepatitis B, and hepatitis C. Diseases caused by drugs, poisons, or too much alcohol. Examples include fatty liver disease and cirrhosis.

Liver diseases encompass a wide range of conditions that affect the liver, an essential organ responsible for numerous vital functions in the body, including metabolism, detoxification, and nutrient storage. 

Some Common Liver Diseases include:

1. Hepatitis: Hepatitis is inflammation of the liver and can be caused by viruses (hepatitis A, B, C, D, and E), alcohol, toxins, medications, or autoimmune disorders. Hepatitis can be acute or chronic and may lead to liver damage or failure if left untreated.

2. Non-Alcoholic Fatty Liver Disease (NAFLD): NAFLD is a condition in which excess fat accumulates in the liver of people who drink little to no alcohol. It is often associated with obesity, insulin resistance, type 2 diabetes, high cholesterol, and metabolic syndrome. NAFLD can progress to non-alcoholic steatohepatitis (NASH), characterized by liver inflammation and damage, and eventually lead to cirrhosis or liver cancer.

3. Alcoholic Liver Disease (ALD): ALD refers to liver damage caused by excessive alcohol consumption. It encompasses a spectrum of conditions, including fatty liver (steatosis), alcoholic hepatitis (inflammation of the liver), fibrosis (scarring), and cirrhosis (irreversible scarring of the liver). ALD can progress to liver failure or liver cancer if drinking continues.

4. Cirrhosis: Cirrhosis is a late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism. The liver tissue is replaced by scar tissue, which can disrupt liver function and lead to complications such as portal hypertension, ascites (fluid buildup in the abdomen), hepatic encephalopathy (brain dysfunction), and liver cancer.

5. Liver Cancer: Liver cancer, also known as hepatocellular carcinoma (HCC), can develop as a primary cancer arising from the liver cells or as a result of metastasis from cancers elsewhere in the body. Risk factors for liver cancer include chronic hepatitis B or C infection, cirrhosis, NAFLD/NASH, ALD, exposure to aflatoxins, and certain genetic conditions.

6. Autoimmune Liver Diseases: Autoimmune liver diseases, such as autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis, occur when the immune system mistakenly attacks the liver, leading to inflammation, damage, and scarring.

7. Genetic Liver Diseases: Genetic liver diseases, such as hemochromatosis, Wilson's disease, alpha-1 antitrypsin deficiency, and various metabolic disorders, result from inherited genetic mutations that affect liver function and metabolism.

Treatment and management of liver diseases depend on the specific condition, its severity, and underlying causes. They may include lifestyle modifications, medications, liver transplantation, and in some cases, supportive care to manage complications and improve quality of life. Early detection and intervention are crucial for preventing progression and improving outcomes in liver diseases. Regular medical check-ups, screening tests, and adherence to treatment plans are essential for individuals at risk or with liver disease.

BENEFITS USING DXN PRODUCTS:

• Detoxifies the Liver
• Reduces the Fat accumulation
• Improves general Liver functions
• Improves vascularity of the Liver
• Helps ‘ Liver-cell Regeneration’
• Improves overall Energy and Digestion capacity

PRODUCTS RECOMMENDATIONS:

• DXN RG&GL
• DXN Spirulina
• DXN Cordyceps
• DXN Roselle Juice
• DXN Morinzhi
• DXN Lingzhi Coffee 3N1

DISCLAIMER: The dietary food supplements presented in this Page are designed to assist in the maintenance of general well-being through regular use. If you have a condition which requires medical diagnosis and treatment, it is important that you visit your healthcare professional.

The information presented on this page is for informational & educational purposes only, and is not intended as a medical advice or a substitute for a physician’s consultation and/or examination.

DXN Black Ginger 370mg Capsule

🌿 Introducing the DXN Black Ginger 370mg Capsule 🌿

Discover the natural strength of Kaempferia parviflora, traditionally known as Black Ginger or Krachai-dam.

Formulated to support your wellness journey, this capsule helps you stay active, confident, and energized every day.

✔️ Helps maintain overall health

✔️ Traditionally used to support vitality

✔️ Available in 30’s and 90’s bottles

📦 Product Codes & Pricing

DXN Black Ginger 370mg Capsule (30’s)

Member Price: 

RM36.10 (West MY) / 

RM37.90 (East MY)

PV 14.00 | SV 22.60

DXN Black Ginger 370mg Capsule (90’s)

Member Price: 

RM97.40 (West MY) / 

RM102.30 (East MY)

PV 37.60 | SV 61.30

🛒 Available now at all DXN Malaysia Branches Nationwide!

🛍️ Shop Online | 💖 Learn more

DXN 29 Net Profit Surges to RM70.26 Mil, Announces 0.80 Sen Dividend

DXN Holdings Bhd’s net profit for the second quarter ended Aug 31, 2025 (2Q 2025), rose to RM70.26 million from RM65.97 million a year earlier. – pic by DXN

DXN Holdings Bhd's net profit for the second quarter ended Aug 31, 2025 (2Q 2025), rose to RM70.26 million from RM65.97 million a year earlier.

However, revenue slipped by 1.5 per cent to RM481.20 million from RM488.43 million previously, said the global health and wellness direct-selling company in a Bursa Malaysia filing today.

"This was due to unfavourable currency translation effects arising from the depreciation of foreign currencies against the ringgit.

"Excluding currency translation effects, revenue in local currencies remained positive, with Peru, Bolivia, Mexico and India recording growth rates ranging from two per cent to 38 per cent," it said.

The company has declared a second interim dividend of 0.80 sen per ordinary share in respect of the financial year ending Feb 28, 2026, payable on Nov 28, 2025.

DXN Holdings added that the Middle East also showed improvement, supported by ongoing market-boosting activities. However, revenue from Morocco declined due to softer demand, as members held higher stock levels following increased purchases during earlier promotional campaigns.

For the six months ended Aug 31, 2025, net profit narrowed to RM144.17 million from RM151.54 million, while revenue eased to RM960.26 million from RM963.49 million a year ago.

On its prospects, the group said it would continue to diversify its product offerings, focusing on functional solutions that support immunity and overall wellness.

"To support long-term growth, the group is expanding its global footprint with new facilities in Peru, Bolivia and Morocco. In addition, it is also expanding into Kelantan, Malaysia.

"These expansions will enhance market access and improve logistics efficiency. In this context, the group remains focused on product innovation, operational scalability and sustainable expansion, which are central to our long-term growth strategy in the wellness sector," it said.

Source: New Straits Times

DXN Expands Latin American Footprint with New Coffee Processing Plant in Brazil

Strategic partnership: The Mayor of Ibia, Minas Gerais, Gillianno Mamao (left), sharing a light moment with Lim in Kuala Lumpur.

KUALA LUMPUR: Malaysian health and wellness direct-selling powerhouse DXN Holdings Bhd (DXN) is strengthening its presence in Latin America with plans to establish a coffee processing facility in Minas Gerais, Brazil.

Its founder and executive chairman Datuk Lim Siow Jin said the move marks the group’s next strategic step in its expansion across the region.

“Brazil is the natural next phase in our Latin American journey. The region continues to drive our growth and Brazil’s market scale, demographics and increasing health consciousness align perfectly with our strong foothold in Peru and Bolivia,” Lim said after the Malaysia-Brazil Business Summit at the Renaissance Hotel Kuala Lumpur.

Joining Lim at the event was Gillianno Mamao, Mayor of Ibia, Minas Gerais.

According to Lim, Latin America currently contributes about 60% of DXN’s total revenue, exceeding RM1bil for the financial year 2025. The region’s share is expected to remain steady in the near term.

He said the Brazil venture will extend beyond traditional coffee processing, involving technology transfer from Malaysia and the introduction of innovative products such as seaweed coffee, fermented civet coffee (kopi luwak) and coffee-leaf tea — a new concept in Brazil’s coffee industry.

“We intend to bring new ideas and technology to Brazil’s coffee sector. Malaysia’s expertise in value-added coffee production is something we’re proud to share,” he added.

To support market entry, DXN established its first registered office in Sao Paulo in April 2024, focusing on regulatory matters, distributor training and operational groundwork.

“Since our launch, we’ve attracted over 11,000 members in Brazil — and the number continues to rise, showing strong local interest in Malaysian-made products,” Lim said.

He noted that Brazil’s climate and soil closely resemble Malaysia’s, allowing DXN to replicate its cultivation and production techniques with minimal adaptation.

“What works in Malaysia can be implemented almost directly there. It also opens doors for Malaysian entrepreneurs keen to expand into Latin America,” he said.

Lim added that the local government has offered significant incentives, including 10ha of free land, simplified investment procedures and lower land costs compared to Malaysia.

“Brazil is investor-friendly — with affordable land, ample space and straightforward licensing. It’s an encouraging environment for Malaysian investors,” he said.

DXN currently maintains a strong foothold across Mexico, Peru and Bolivia, with over 10 million active members worldwide, of which 60% are based in Latin America.

Meanwhile, Mamao voiced his full support for the project, saying it reflects Brazil’s growing partnership with Malaysia.

“As Mayor of Ibia, I welcome DXN’s plan to establish a major facility in our city. As our president Luiz Inacio Lula da Silva has said, Brazil and Malaysia will continue to be strategic partners in investment and joint development,” he said.

SOURCE: The Star

DXN Mulling Coffee-Processing Factory in Brazil

KUALA LUMPUR (Oct 27): DXN Holdings Bhd (KL:DXN EDGE) said the company has plans to establish a coffee-processing factory in Minas Gerais, Brazil.

Its founder and executive chairman Datuk Lim Siow Jin said the move marks DXN’s entry into the biggest market in Latin America.

“Brazil is the next logical step in Latin America. The region is now leading the group’s growth, and we see the economies of scale, demographic profile and health-lifestyle awareness in Brazil as complementary to our strong presence in Peru and Bolivia,” said Lim at the Malaysia-Brazil Business Summit in Kuala Lumpur.

He said the Latin America market currently contributes about 60% — or over RM1 billion — to the group’s total revenue for the financial year ended Feb 28, 2025 (FY2025), and this share is expected to remain stable in the near term.

DXN currently has a strong presence in Mexico, Peru and Bolivia, with more than 10 million active members globally, of which 60% are in Latin America.

The investment in Brazil will involve both the construction of the coffee-processing facility and the transfer of Malaysian technology — including production of civet-style fermented coffee and tea made from coffee leaves, an innovation that is considered new to the Brazilian market.

“We plan to bring this technology to Brazil to introduce a new concept in the Brazilian coffee industry. Malaysia has strong expertise in developing value-added coffee products,” Lim said.

According to Lim, Brazil was chosen due to its similar climate and soil conditions to Malaysia’s, which allow for the cultivation and production of raw materials using DXN’s existing technology.

“What we plant and produce in Malaysia can be implemented there without many adjustments. This is a great opportunity for Malaysian entrepreneurs who want to expand their businesses into the region,” he said.

He added that the local government has offered attractive incentives, including 10 hectares of free land for the project, simplified investment procedures and lower land costs.

DXN’s share price closed up one sen or 1.94% to 52.5 sen on Monday, giving the group a market capitalisation of RM2.62 billion.

SOURCE: The Edge Malaysia

Ancient Wellness, Modern Impact

From a quiet town in Kedah, Malaysia, a wellness revolution has taken root. DXN Holdings Bhd, a vertically integrated nutraceutical manufacturer, has grown into one of Asia’s most trusted global wellness companies. Today, DXN operates in more than 180 countries, producing and distributing nutraceuticals including beverages, supplements, and skincare products to more than 20 million consumers.

At the core of DXN’s success is a unique business model: a fully integrated ecosystem spanning agricultural cultivation, research and development, manufacturing, and direct sales. This end-to-end system ensures quality control, sustainability, and affordability. The foundation is lingzhi mushrooms, revered for centuries as the “king of herbs.” Now, DXN has modernized an ancient wellness practice, combining biotechnology and sustainable innovation to scale wellness globally.

Leading this transformation is Datuk Lim Siow Jin, DXN’s founder and executive chairman, whose philosophy of “One World, One Market” transcends borders. His vision of inclusion has created opportunities for millions of distributors and families worldwide.

“At the heart of DXN’s success is our belief that sustainability and innovation begin with people,” says Lim. “Our purpose isn’t just selling wellness products; it’s building a system that uplifts human dignity and prosperity.”

In an era focused on ethical supply chains, DXN sets new benchmarks in human-rights due diligence. Its “direct worker voice” initiative provides every worker with secure, unfiltered communication channels to management. Through QR code access and verified digital IDs, workers anonymously report on safety and well-being. The system ensures data authenticity and gives workers ownership of their data as well as financial incentives for participation.

This breakthrough has led to measurable improvements in workplace well-being, facility design, and employee engagement. In DXN’s model, transparency isn’t compliance—it’s a competitive advantage.

DXN’s innovation extends from people to processes. Across its 14 manufacturing plants and eight cultivation facilities in seven countries, the company invests in AI-driven quality control, smart manufacturing, renewable energy, and zero-waste operations. These innovations boost efficiency while reducing carbon intensity, reinforcing DXN’s commitment to sustainable growth. By aligning purpose with profitability, DXN aims to shift sustainability from a cost center to a growth engine.

As DXN expands globally—from Malaysia to Mexico and Dubai to Delhi—its mission remains constant: Wellness for all. For Lim, the company’s evolution reflects moral conviction.

“Our journey shows that scale and soul can coexist,” Lim says. “A business built on human empowerment will always be relevant, because it grows from the same roots as society itself.”

SOURCE: Fortune